Pretreatment Pan-Immune-Inflammation Value (PIV) in Predicting Therapeutic Response and Clinical Outcomes of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma
Ji‐Feng Feng, Liang Wang, Xun Yang, Qixun Chen, Xiangdong Cheng
Topics & Concepts
MedicineHazard ratioInternal medicineConfidence intervalOncologyProportional hazards modelEsophageal cancerEsophagectomySurgical oncologyOdds ratioNeoadjuvant therapyRetrospective cohort studyGastroenterologyEsophageal squamous cell carcinomaPathologicalCarcinomaImmune systemCancerImmunologyBreast cancerInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis